Breaking News

IPS Names Process Engineering Director

By Kristin Brooks | January 23, 2014

Schuster brings 25 years of global experience

Tim Schuster has been appointed director of Process Engineering at IPS-Integrated Project Services, Inc. and will be based at the company’s corporate headquarters in Blue Bell, PA.
 
Mr. Schuster has 25 years of global experience in bioprocess engineering, project management and facility and critical utilities systems design, having executed projects in Europe, Asia/Pacific and the U.S. He has expertise with leading technologies within bioprocess and biomanufacturing, including fermentation, single-use systems, process design, large-scale cell culture, recovery, vaccines, isolation and purification. Prior to joining the company, Mr. Schuster held technical leadership positions at Biokinetics, Foster Wheeler and Washington Group International.  
 
“We are pleased to have an expert of Tim’s caliber join IPS,” said Dave Goswami, PE, chief executive officer and chairman, IPS. “Tim brings state-of-the-art knowledge of bioprocess engineering and his experience in complex biotechnology projects in various parts of the world will be a great complement to the strong Biotechnology Team that IPS has developed. The addition of Tim is in line with our focus on becoming the top service provider in the biotechnology sector.”
blog comments powered by Disqus
  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors

  • Platinum Press Facility Tour

    Platinum Press Facility Tour

    Kristin Brooks, Contract Pharma||March 23, 2016
    Opens doors to new, 47,000-sq.-ft. packaging facility in Oakland, NJ

  • Biopharma Packaging Equipment Close-up

    Biopharma Packaging Equipment Close-up

    Kristin Brooks, Contract Pharma||March 7, 2016
    Sieghard Schuchmann of OPTIMA discusses biopharma trends impacting packaging equipment, and the latest capabilities

  • Single-use Technology Integral to Advancing Biomanufacturing

    Single-use Technology Integral to Advancing Biomanufacturing

    Nigel Walker, Thatu2019s Nice LLC / Nice Insight||March 9, 2016
    Innovative process technologies are a necessity for today’s biopharmaceutical contract manufacturers

  • Consolidation in Outsourcing

    Consolidation in Outsourcing

    Michael A. Martorelli, Fairmount Partners||March 9, 2016
    Reviewing 2015’s M&A activity

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.